Matilde Marques
- Indexed articles, last 90 days
- 5
- Latest publication
- Sep 28, 2026
- Outlet visibility, for Selectscience
- Top 5M sites
- Earliest in this view
- Jul 7, 2026
Latest articles
How automation can reduce variability in cell culture - SelectScience interview (opens the original)
Read excerpt
Cell culture is often described as more art than science, where a steady hand can matter as much as the written protocol. Even in labs that follow rigorous standard operating procedures, results can vary across runs, operators or passages, leaving scientists to wonder whether they are seeing genuine biological signal or an artifact of process. Few people understand this tension better than Yannik Breitkreuz, Product Manager for Cell Biology at Hamilton, a global leader in automated liquid handli
Genomics goes mainstream across research and healthcare - SelectScience interview (opens the original)
Read excerpt
A decade ago, genomics was still regarded by many as an emerging technology with enormous potential but significant practical limitations. Today, that picture looks very different. Sequencing has become a routine part of workflows across research, healthcare, agriculture, and biotechnology, helping scientists answer increasingly complex questions about disease, biological function, and genetic diversity. For Leandro Neves, Senior Global Director of R&D Genomics at LGC, one of the most significan
Optimizing ddPCR assay design for cancer monitoring - SelectScience interview (opens the original)
Read excerpt
Cancer biology does not change based on where a patient lives, but access to timely molecular diagnostics often does. At a major cancer center, a patient’s tumor may be monitored with tests sensitive enough to detect only a few mutant DNA molecules, while patients elsewhere may wait weeks for even basic testing, if it is available at all. For clinicians and researchers seeking to monitor disease progression, treatment response, and minimal residual disease (MRD), that gap can influence how quick
Single-cell metabolomics and AI for predictive toxicology - SelectScience interview (opens the original)
Read excerpt
Metabolomics offers a uniquely direct view of cellular function. While genomics can indicate what a cell is capable of doing and transcriptomics can reveal changes in gene expression, metabolomics captures the downstream molecular activity that more closely reflects what a cell is doing at a given moment. For Theodore Alexandrov, CEO and co-founder of DeepCyte, this makes metabolomics particularly valuable for understanding how cells respond to drugs, toxicants, and changes in their environment.
How to Buy PCR Technology | SelectScience (opens the original)
Read excerpt
Looking to boost sensitivity, improve reproducibility, or scale PCR workflows? Download this expert SelectScience guide to cut through the complexity of qPCR, digital PCR, and droplet digital PCR, and confidently choose the technologies that will strengthen data quality, streamline workflows, and future-proof your lab. Polymerase chain reaction (PCR) is one of the most widely used molecular biology techniques for amplifying, detecting, and analyzing DNA and RNA. By enabling laboratories to gene
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Selectscience, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.